Cargando…

COVID-19 Survival and its impact on chronic kidney disease

Up to 87% of patients hospitalized with coronavirus disease 2019 (COVID-19) experience chronic sequelae following infection. The long-term impact of COVID-19 infection on kidney function is largely unknown at this point in the COVID-19 pandemic. In this review, we highlight the current understanding...

Descripción completa

Detalles Bibliográficos
Autores principales:	LONG, JOSHUA D., STROHBEHN, IAN, SAWTELL, RANI, BHATTACHARYYA, ROBY, SISE, MEGHAN E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579714/ https://www.ncbi.nlm.nih.gov/pubmed/34774843 http://dx.doi.org/10.1016/j.trsl.2021.11.003

Ejemplares similares

Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function
por: Seethapathy, Rituvanthikaa, et al.
Publicado: (2023)

Acute Kidney Injury Incidence, Recovery, and Long-term Kidney Outcomes Among Hospitalized Patients With COVID-19 and Influenza
por: Strohbehn, Ian A., et al.
Publicado: (2021)

Phase-3 Randomized Controlled Trials on Exclusion of Participants With Kidney Disease in COVID-19
por: Chewcharat, Api, et al.
Publicado: (2020)

Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer
por: Hanna, Paul E., et al.
Publicado: (2023)

Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study
por: Tiu, Bruce C, et al.
Publicado: (2023)

Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma
por: Seethapathy, Harish, et al.
Publicado: (2020)

Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma
por: Wang, Qiyu, et al.
Publicado: (2022)

Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus
por: Sise, Meghan E., et al.
Publicado: (2020)

Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m(2) or on Renal Replacement Therapy
por: Estiverne, Christopher, et al.
Publicado: (2020)

Prescription Patterns of Osteoporosis Medications in Patients With Advanced CKD: A Retrospective Cohort Study
por: Portales-Castillo, Ignacio A., et al.
Publicado: (2021)

Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C–Viremic Donor to Uninfected Recipient Kidney Transplantation
por: Sise, Meghan E., et al.
Publicado: (2020)

Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19
por: Ng, Jia H., et al.
Publicado: (2020)

Safety and Efficacy of Paritaprevir/Ritonavir, Ombitasvir, and Dasabuvir for Hepatitis C Virus Infection Across All Levels of Kidney Function
por: Sise, Meghan E.
Publicado: (2018)

Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study
por: Lee, Meghan D, et al.
Publicado: (2021)

The association between olfactory and gustatory dysfunction and chronic kidney disease
por: Chewcharat, Api, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management
por: Seethapathy, Harish, et al.
Publicado: (2021)

Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors
por: Seethapathy, Harish, et al.
Publicado: (2020)

Structural and physiological changes of the kidney with age and its impact on chronic conditions and COVID-19
por: Ray, Nandini, et al.
Publicado: (2023)

Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR
por: Hanna, Paul E., et al.
Publicado: (2023)

The impact of chronic kidney disease in diabetic COVID-19 patients
por: Chaabouni, Hana, et al.
Publicado: (2022)

Medication-Related Adverse Events and Discordancies in Cystatin C–Based vs Serum Creatinine–Based Estimated Glomerular Filtration Rate in Patients With Cancer
por: Hanna, Paul E., et al.
Publicado: (2023)

Acute kidney injury without need for dialysis, incidence, its impact on long-term stroke survival and progression to chronic kidney disease
por: Pande, Shrikant D, et al.
Publicado: (2022)

Physician Attitudes on Kidney Biopsies for Research: A Survey Study
por: McMahon, Gearoid M., et al.
Publicado: (2019)

COVID-19 and its impact on the kidney and the nephrology community
por: Soler, María José, et al.
Publicado: (2021)

Impact of Chronic Kidney Disease on Survival After Amputation in Individuals With Diabetes
por: Lavery, Lawrence A., et al.
Publicado: (2010)

The impact of COVID-19 in diabetic kidney disease and chronic kidney disease: A population-based study
por: Leon-Abarca, Juan Alonso, et al.
Publicado: (2020)

Chronic Kidney Disease and COVID-19
por: Roy, Manas Pratim
Publicado: (2022)

Impact of non-dialysis chronic kidney disease on survival in patients with septic shock
por: Maizel, Julien, et al.
Publicado: (2013)

One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial
por: Sise, Meghan Elizabeth, et al.
Publicado: (2021)

Therapeutic advances in COVID-19
por: Murakami, Naoka, et al.
Publicado: (2022)

Impact of Hospitalization on the Quality of Life of Patients with Chronic Kidney Disease in Saudi Arabia
por: Jalal, Sahbanathul Missiriya, et al.
Publicado: (2022)

COVID-19 Pandemic Causing Acute Kidney Injury and Impact on Patients With Chronic Kidney Disease and Renal Transplantation
por: Adapa, Sreedhar, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on patients with chronic kidney disease: A narrative review
por: Huang, Wanbing, et al.
Publicado: (2022)

Monomeric neutrophil gelatinase associated lipocalin is associated with tubulointerstitial damage in chronic kidney disease
por: Nickolas, Thomas L., et al.
Publicado: (2012)

Burden of chronic kidney disease and its risk factors in Malaysia
por: Begum, Rubina, et al.
Publicado: (2016)

Author Correction: Therapeutic advances in COVID-19
por: Murakami, Naoka, et al.
Publicado: (2023)

Reply to ‘Use of convalescent plasma in the treatment of COVID-19’
por: Murakami, Naoka, et al.
Publicado: (2023)

Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection
por: Lin, Ming V., et al.
Publicado: (2016)

Impact of Chronic Kidney Disease on Risk of Incident Atrial Fibrillation and Subsequent Survival in Medicare Patients
por: Nelson, Sarah E., et al.
Publicado: (2012)

Evaluation of the impact of chronic kidney disease on the survival of octogenarian patients submitted to percutaneous coronary intervention
por: de Franca, Julio Cesar Queiroz, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ju7oibnunojk1cgumg9lbqu4ci